黑龙江珍宝岛药业股份有限公司关于控股股东 非公开发行可交换公司债券换股价格调整的提示性公告

Group 1 - The core point of the announcement is the adjustment of the conversion price for the exchangeable bonds issued by the controlling shareholder, Heilongjiang Chuangda Group, to protect the interests of bondholders [1][2] - The first phase of the exchangeable bonds, named "23 Chuang 01 EB," was issued on April 11, 2023, with a total scale of 910 million yuan and a maturity of three years [1] - The conversion price has been revised from 13.35 yuan per share to 12.35 yuan per share, effective from August 27, 2025, following the approval of the bondholders [2] Group 2 - The adjustment of the conversion price is based on the average closing price of the company's stock over the 20 trading days prior to the board resolution and the closing price on the day before the resolution [2] - The number of shares pledged for the exchangeable bonds will still meet the total required for the conversion after the price adjustment [2] - The company will continue to monitor the progress of the exchangeable bonds and fulfill its ongoing information disclosure obligations [2]